YKYouichi Kawano

Youichi Kawano

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Youichi Kawano has a total of 19 co-authors. Here are the top co-authors by number of shared publications:

  • Hideo Kawarasaki

    Department of Transplant Surgery, Center for Molecular Medicine, Jichi Medical University, Tochigi, Japan

    2 shared publications
  • Koichi Mizuta

    Department of Transplant Surgery, Center for Molecular Medicine, Jichi Medical University, Tochigi, Japan

    2 shared publications
  • Satoshi Egami

    Department of Transplant Surgery, Center for Molecular Medicine, Jichi Medical University, Tochigi, Japan

    2 shared publications
  • Shuji Hisikawa

    Department of Transplant Surgery, Center for Molecular Medicine, Jichi Medical University, Tochigi, Japan

    2 shared publications
  • Takehito Fujiwara

    Department of Surgery, Center for Molecular Medicine, Jichi Medical University, Tochigi, Japan

    2 shared publications
  • Yoshikazu Yasuda

    Department of Surgery, Center for Molecular Medicine, Jichi Medical University, Tochigi, Japan

    2 shared publications

Latest Publications

  • Open Access

    Diagnosis and treatment of pediatric patients with late-onset portal vein stenosis after living donor liver transplantation

    by Youichi Kawano, Koichi Mizuta, Yasuhiko Sugawara, Satoshi Egami, Shuji Hisikawa, Yukihiro Sanada, Takehito Fujiwara, Yasunaru Sakuma, Masanobu Hyodo, Yoshiyuki Yoshida, et al.

    Portal vein stenosis (PVS) after living donor liver transplantation (LDLT) is a serious complication that can lead to graft failure. Few studies of the diagnosis and treatment of late‐onset (≥3 months after liver transplantation) PVS have been reported. One hundred thirty‐three pediatric (median age 7.6 years, range 1.3–26.8 years) LDLT recipients were studied. The patients were followed by Doppler ultrasound (every 3 months) and multidetector helical computed tomography (once a year). Twelve patients were diagnosed with late‐onset PVS 0.5–6.9 years after LDLT. All cases were successfully treated with balloon dilatation. Five cases required multiple treatments. Early diagnosis of late‐onset PVS and interventional radiology therapy treatment may prevent graft loss.


  • Successful pediatric living donor liver transplantation from carrier to carrier of hereditary butyrylcholinesterase variant

    by Youichi Kawano, Koichi Mizuta, Shuji Hisikawa, Takeshi Saito, Satoshi Egami, Yuka Takatsuka, Yukihiro Sanada, Takehito Fujiwara, Yoshikazu Yasuda, Masami Ohmori, et al.

    Hypocholinesterasemia is often observed clinically, especially in various liver diseases. Not well known, however, is the fact that some patients have a hereditary BChE variant. Little has been reported on liver transplants associated with this hereditary BChE variant. Furthermore, no cases have been reported of a LDLT involving hereditary BChE variant that had been diagnosed preoperatively. A 23‐month‐old girl who had had a failed Kasai operation for biliary atresia underwent a liver transplant using as a graft her father’s lateral segment. Preoperatively, she had been diagnosed with hypocholinesterasemia. As the donor, her father had undergone a preoperative examination, during which he was found to also have hypocholinesterasemia. DNA sequencing revealed that both had the hereditary BChE variant. The unique mutation caused a frame‐shift mutation. Variant K was also detected. The patient was discharged 143 days after the operation and has had no problems with immunosuppression since. In conclusion, we report that the hereditary BChE variant is not a contraindication for either transplantation or living liver donation.